Overview
Seisuke Okazawa practices in Toyama, Japan. Okazawa is rated as an Advanced expert by MediFind in the treatment of IgG4-Related Disease. Their top areas of expertise are IgG4-Related Disease, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).
Their clinical research consists of co-authoring 46 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- IgG4-Related DiseaseOkazawa isAdvanced. Learn about IgG4-Related Disease.
- Lung CancerOkazawa isAdvanced. Learn about Lung Cancer.
- Experienced
- AsthmaOkazawa isExperienced. Learn about Asthma.
- Lung AdenocarcinomaOkazawa isExperienced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Pure Red Cell AplasiaOkazawa isExperienced. Learn about Pure Red Cell Aplasia.
- Small Cell Lung Cancer (SCLC)Okazawa isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaOkazawa isExperienced. Learn about Squamous Cell Lung Carcinoma.